Agilis Biotherapeutics

Agilis Biotherapeutics is focused on designing and engineering DNA-based therapeutics for life-threatening or fatal rare diseases.

Agilis Biotherapeutics, LLC is a biotechnology company focused on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. We believe that engineered DNA-based therapeutics provide the ability to target underlying disease mechanisms with tightly-controlled multigenic modalities leading to “functional cures” for patients with these diseases.